Achilles Therapeutics (ACHL)
1.48
0.00 (0.00%)
At close: Mar 20, 2025, 3:59 PM
Achilles Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Hold
Price Target
4
Upside
170.27
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Piper Sandler | Hold | Downgrades | 8 2 | 35.14% | Apr 5, 2024 | |
| Chardan Capital | Buy | Maintains | 11 6 | 305.41% | Apr 5, 2024 | |
| B of A Securities | Sell | Downgrades | 7 1 | -66.22% | Dec 14, 2023 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.